Jack Lu, Director of Corporate Development, joined us on the WTR Small-Cap Spotlight podcast to discuss Veldona, Ainos’ clinical stage low-dose interferon-α (IFN-α) therapeutic.
What is covered in the Full Insight:
Introduction
Overview of Veldona
Clinical History and Studies
Market Opportunities in Human and Animal Health
Regulatory and Development Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.